Clot Risk High With Oral Contraceptives for Those at Genetic Risk

Follow Drugslib on

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

FRIDAY, Dec. 1, 2023 -- Oral contraceptive (OC) use is associated with an increased risk for developing a venous thromboembolism (VTE), particularly among women with a high genetic predisposition, according to a study recently published online in the American Journal of Obstetrics & Gynecology.

Valeria Lo Faro, Ph.D., from Uppsala University in Sweden, and colleagues estimated the risk for developing VTE when initiating OC use (first two years) and during continued use among women with a high genetic liability. The analysis included 244,420 participants in the U.K. Biobank.

The researchers found that overall, there was an increased risk for VTE during the first two years of OC use (hazard ratio [HR], 3.09; 95 percent confidence interval [CI], 3.00 to 3.20) but not during continued use (HR, 0.92; 95 percent CI, 0.80 to 1.05). When considering genetic risk, women in the highest polygenic risk score group had a more pronounced risk for VTE during the first two years of OC use. Similarly, high risk was seen among factor V Leiden and prothrombin variant carriers. The combination of a high polygenic risk score and being a factor V Leiden and prothrombin variant carrier conferred the highest risk for developing a VTE during the first two years of OC use (HR, 14.8; 95 percent CI, 9.28 to 23.6). During continued use, women with a high genetic liability also had increased VTE risk, but it was less pronounced.

"This is important knowledge for women’s health and may be important in contraception counselling," Lo Faro said in a statement.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-12-02 00:34

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords